TY - JOUR
T1 - Correction to
T2 - New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version) (Diabetology International, (2024), 15, 1, (1-4), 10.1007/s13340-023-00679-1)
AU - Shimada, Akira
AU - Kawasaki, Eiji
AU - Abiru, Norio
AU - Awata, Takuya
AU - Oikawa, Yoichi
AU - Osawa, Haruhiko
AU - Kajio, Hiroshi
AU - Kozawa, Junji
AU - Takahashi, Kazuma
AU - Chujo, Daisuke
AU - Noso, Shinsuke
AU - Fukui, Tomoyasu
AU - Miura, Junnosuke
AU - Yasuda, Kazuki
AU - Yasuda, Hisafumi
AU - Imagawa, Akihisa
AU - Ikegami, Hiroshi
N1 - Publisher Copyright:
© The Japan Diabetes Society 2024.
PY - 2024/7
Y1 - 2024/7
N2 - In the original publication of the article, under the discussion section, in the following paragraph “Moreover, regarding the concept of …”, “for” should be replaced with “at” in the third point. The correct sentence should read as follows “(3) insulin treatment required at more than 6 months after the diagnosis of diabetes.” Similarly, under the same section, in the following paragraph “According to the IDS diagnostic criteria for…”, “for” should be replaced with “at” in a few occurrences. The correct sentences should read as follows “According to the IDS diagnostic criteria for LADA, insulin treatment is required at more than 6 months [4] after the diagnosis of diabetes. However, considering the diagnostic criteria of AT1D [6], we described the necessity of insulin treatment at more than 3 months in the new criteria of SPIDDM (2023) and added a comment on the necessity of insulin treatment at more than 6 months after diagnosis of diabetes in typical cases.” Finally, in Table 1, on third factor, “for” should be replaced with “at”. The correct sentence should read as follows “(3) Gradual reduction in insulin secretion overtime, requirement of insulin treatment at more than 3 monthsb after diagnosis of diabetes, and severe endogenous insulin deficiency (fasting serum C-peptide immunoreactivity < 0.6 ng/mL) at the last observed time point”.
AB - In the original publication of the article, under the discussion section, in the following paragraph “Moreover, regarding the concept of …”, “for” should be replaced with “at” in the third point. The correct sentence should read as follows “(3) insulin treatment required at more than 6 months after the diagnosis of diabetes.” Similarly, under the same section, in the following paragraph “According to the IDS diagnostic criteria for…”, “for” should be replaced with “at” in a few occurrences. The correct sentences should read as follows “According to the IDS diagnostic criteria for LADA, insulin treatment is required at more than 6 months [4] after the diagnosis of diabetes. However, considering the diagnostic criteria of AT1D [6], we described the necessity of insulin treatment at more than 3 months in the new criteria of SPIDDM (2023) and added a comment on the necessity of insulin treatment at more than 6 months after diagnosis of diabetes in typical cases.” Finally, in Table 1, on third factor, “for” should be replaced with “at”. The correct sentence should read as follows “(3) Gradual reduction in insulin secretion overtime, requirement of insulin treatment at more than 3 monthsb after diagnosis of diabetes, and severe endogenous insulin deficiency (fasting serum C-peptide immunoreactivity < 0.6 ng/mL) at the last observed time point”.
UR - http://www.scopus.com/inward/record.url?scp=85186947466&partnerID=8YFLogxK
U2 - 10.1007/s13340-024-00702-z
DO - 10.1007/s13340-024-00702-z
M3 - コメント/討論
C2 - 39101174
AN - SCOPUS:85186947466
SN - 2190-1678
VL - 15
SP - 638
EP - 639
JO - Diabetology International
JF - Diabetology International
IS - 3
ER -